34 research outputs found
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
BACKGROUND: Few studies have examined the impact of treatment-related morbidity on long-term, cause-specific mortality in Hodgkin lymphoma (HL) patients. METHODS: This multicenter cohort included 4919 HL patients, treated before age 51 years between 1965 and 2000, with a median follow-up of 20.2âyears. Standardized mortality ratios, absolute excess mortality (AEM) per 10â000 person-years, and cause-specific cumulative mortality by stage and primary treatment, accounting for competing risks, were calculated. RESULTS: HL patients experienced a 5.1-fold (AEM = 123 excess deaths per 10â000 person-years) higher risk of death due to causes other than HL. This risk remained increased in 40-year survivors (standardized mortality ratio = 5.2, 95% confidence interval [CI] = 4.2 to 6.5, AEM = 619). At age 54âyears, HL survivors experienced similar cumulative mortality (20.0%) from causes other than HL to 71-year-old individuals from the general population. Whereas HL mortality statistically significantly decreased over the calendar period (Pâ<â.001), solid tumor mortality did not change in the most recent treatment era. Patients treated in 1989-2000 had lower 25-year cardiovascular disease mortality than patients treated in 1965-1976 (4.3% vs 5.7%; subdistribution hazard ratio = 0.65, 95% CI = 0.46 to 0.93). Infectious disease mortality was not only increased after splenectomy but also after spleen irradiation (hazard ratio = 2.81, 95% CI = 1.55 to 5.07). For stage I-II, primary treatment with chemotherapy (CT) alone was associated with statistically significantly higher HL mortality (Pâ<â.001 for CT vs radiotherapy [RT]; Pâ=â.04 for CT vs RT+CT) but lower 30-year mortality from causes other than HL (15.8%, 95% CI = 9.7% to 23.3%) compared with RT alone (36.9%, 95% CI = 34.0% to 39.8%, Pâ=â.001) and RT and CT combined (29.8%, 95% CI = 26.8% to 32.9%, Pâ=â.02). CONCLUSIONS: Compared with the general population, HL survivors have a substantially reduced life expectancy. Optimal selection of patients for primary CT is crucial, weighing risks of HL relapse and long-term toxicity
Updating temporal expectancy of an aversive event engages striatal plasticity under amygdala control
Pavlovian aversive conditioning requires learning of the association between a conditioned stimulus (CS) and an unconditioned, aversive stimulus (US) but also involves encoding the time interval between the two stimuli. The neurobiological bases of this time interval learning are unknown. Here, we show that in rats, the dorsal striatum and basal amygdala belong to a common functional network underlying temporal expectancy and learning of a CSâUS interval. Importantly, changes in coherence between striatum and amygdala local field potentials (LFPs) were found to couple these structures during interval estimation within the lower range of the theta rhythm (3â6 Hz). Strikingly, we also show that a change to the CSâUS time interval results in long-term changes in cortico-striatal synaptic efficacy under the control of the amygdala. Collectively, this study reveals physiological correlates of plasticity mechanisms of interval timing that take place in the striatum and are regulated by the amygdala
Updating temporal expectancy of an aversive event engages striatal plasticity under amygdala control
Pavlovian aversive conditioning requires learning of the association between a conditioned stimulus (CS) and an unconditioned, aversive stimulus (US) but also involves encoding the time interval between the two stimuli. The neurobiological bases of this time interval learning are unknown. Here, we show that in rats, the dorsal striatum and basal amygdala belong to a common functional network underlying temporal expectancy and learning of a CSâUS interval. Importantly, changes in coherence between striatum and amygdala local field potentials (LFPs) were found to couple these structures during interval estimation within the lower range of the theta rhythm (3â6 Hz). Strikingly, we also show that a change to the CSâUS time interval results in long-term changes in cortico-striatal synaptic efficacy under the control of the amygdala. Collectively, this study reveals physiological correlates of plasticity mechanisms of interval timing that take place in the striatum and are regulated by the amygdala
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 r4ra randomized trial
Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without previous knowledge of target expression levels in the diseased tissue. Approximately 40% of patients do not respond to individual biologic therapies and 5â20% are refractory to all. In a biopsy-based, precision-medicine, randomized clinical trial in RA (R4RA; nâ=â164), patients with low/absent synovial Bâcell molecular signature had a lower response to rituximab (anti-CD20 monoclonal antibody) compared with that to tocilizumab (anti-IL6R monoclonal antibody) although the exact mechanisms of response/nonresponse remain to be established. Here, in-depth histological/molecular analyses of R4RA synovial biopsies identify humoral immune response gene signatures associated with response to rituximab and tocilizumab, and a stromal/fibroblast signature in patients refractory to all medications. Post-treatment changes in synovial gene expression and cell infiltration highlighted divergent effects of rituximab and tocilizumab relating to differing response/nonresponse mechanisms. Using ten-by-tenfold nested cross-validation, we developed machine learning algorithms predictive of response to rituximab (area under the curve (AUC)â=â0.74), tocilizumab (AUCâ=â0.68) and, notably, multidrug resistance (AUCâ=â0.69). This study supports the notion that disease endotypes, driven by diverse molecular pathology pathways in the diseased tissue, determine diverse clinical and treatmentâresponse phenotypes. It also highlights the importance of integration of molecular pathology signatures into clinical algorithms to optimize the future use of existing medications and inform the development of new drugs for refractory patients
Detection and localization of early- and late-stage cancers using platelet RNA
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for cancer detection, as they alter their RNA content upon local and systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the detection of 18 cancer types. With 99% specificity in asymptomatic controls, thromboSeq correctly detected the presence of cancer in two-thirds of 1,096 blood samples from stage IâIV cancer patients and in half of 352 stage IâIII tumors. Symptomatic controls, including inflammatory and cardiovascular diseases, and benign tumors had increased false-positive test results with an average specificity of 78%. Moreover, thromboSeq determined the tumor site of origin in five different tumor types correctly in over 80% of the cancer patients. These results highlight the potential properties of TEP-derived RNA panels to supplement current approaches for blood-based cancer screening
De la polaritĂ© planaire Ă lâanatomie pathologique des photorĂ©cepteurs par la Microscopie en expansion
L'effet Stiles-Crawford (SCE) est un effet psychophysique, caractĂ©risĂ© par la diffĂ©rence dâintensitĂ© perçue entre un faisceau passant par le centre de la pupille (perçu comme plus lumineux) et un faisceau passant par sa pĂ©riphĂ©rie. Son mĂ©canisme physiologique est attribuĂ© Ă un alignement des photorĂ©cepteurs vers l'ouverture pupillaire par phototropisme. Nous avons concentrĂ© nos recherches sur un complexe protĂ©ique pouvant expliquer cet effet : l'interactome des protĂ©ines Usher. La fonction de cet interactome dans les photorĂ©cepteurs est inconnue. Nous proposons ici qu'Ă l'instar de son rĂŽle dans les cellules ciliĂ©es d'audition, il pourrait jouer un rĂŽle mĂ©canique dans les cĂŽnes. Nous avons utilisĂ© la microscopie Ă expansion comme technique de super-rĂ©solution pour Ă©tudier la distribution 3D dĂ©taillĂ©e des protĂ©ines du syndrome de Usher et du cytosquelette dans les photorĂ©cepteurs de primates. Nous avons montrĂ© que ce rĂ©seau protĂ©ique peut expliquer le maintien de l'alignement des compartiments dâun cĂŽne malgrĂ© les contraintes mĂ©caniques voire un alignement actif par dĂ©formation du rĂ©seau dâactine. Nous avons de plus dĂ©couvert que les cĂŽnes suivent une polaritĂ© planaire dans la rĂ©tine centrĂ©e autour de la fovĂ©a. Cette orientation spĂ©cifique pourrait contribuer au phototropisme associĂ© au SCE. Pour permettre lâobservation future de cet alignement Ă lâĂ©chelle de la rĂ©tine entiĂšre, nous avons utilisĂ© la microscopie Ă expansion pour amĂ©liorer la rĂ©solution de la microscopie en feuille de lumiĂšre. Ce couplage de techniques nous a permis de dĂ©velopper un nouvel outil inestimable pour l'observation immunohistochimique normale et pathologique de la rĂ©tine entiĂšre.The Stiles-Crawford effect (SCE) is a psychophysical effect, stating that the intensity of a light beam will be perceived as more intense if it passes through the center of the pupil rather than through its periphery. Its physiological basis has been attributed to an alignment of photoreceptors toward the pupillary aperture through an active phototropism. We focused our investigation on a candidate protein complex to underlie that effect: the Usher protein interactome. Its function in photoreceptors is unknown but we here propose that, similarly to its role in audition hair cells, it could play a mechanical role in cones. We used Expansion microscopy as a super-resolution technique to investigate Usher and cytoskeleton protein detailed 3D distribution in primate photoreceptors. We showed that this protein network can explain the maintained alignment of the inner in cone despite external mechanical stress. Seeing the asymmetry of photoreceptor, we discovered that cones follow a planar cellular polarity in the retina centered around the fovea. This organisation may likely play a role in the photoreceptors orientation and alignment. It could contribute to the phototropism associated to the SCE with actin filaments acting as push-pull strings on the inner/outer segments. To observe the whole photoreceptor mosaic, we implemented expansion microscopy as a resolution enhancer to light-sheet microscopy. This allows us to developed a useful tool for normal and pathological immunohistochemistry observation of the whole retina
Physical therapy in adult inflammatory myopathy patients: a systematic review
The safety and effect of physical therapy in adult patients with idiopathic inflammatory myopathies (IIMs) are currently unclear. Considering the muscle weakness resulting from disease activity as well as from the administered drugs, these patients could benefit from an evidence-based physical therapy program. To perform a systematic review to assess safety and effects of physical therapy on the functional outcome of patients with idiopathic inflammatory myopathies in both active and quiescent disease: Pubmed, Embase, and Cochrane. Patients with one of the following idiopathic inflammatory myopathies: polymyositis, dermatomyositis, immune-mediated necrotizing myopathy, and/or overlap myositis. The intervention included several types of rehabilitation programs, from strength and resistance training to endurance training, with a minimal duration of 1Â month. Studies reporting intervention-related adverse events, disease activity, and functional outcomes were eligible. The risk of bias was assessed using the Cochrane guidelines. We included five randomized controlled and seven open-label non-randomized non-controlled trials. Data on statistical significance were extracted for all the trials. Included trials were of medium-quality evidence given the low number of patients and some risk of bias factors. Physical therapy does not have a negative effect on the disease activity of idiopathic inflammatory myopathies in quiescent disease and could improve functional outcome. The physical therapy program should minimally include endurance training. A combination with resistance training might be beneficial.status: publishe